Your browser doesn't support javascript.
loading
Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.
Girard, Jennifer; Reneau, John; Devata, Sumana; Wilcox, Ryan A; Kaminski, Mark S; Mercer, Jessica; Carty, Shannon; Phillips, Tycel J.
Affiliation
  • Girard J; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Reneau J; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Devata S; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Wilcox RA; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Kaminski MS; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Mercer J; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Carty S; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
  • Phillips TJ; Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI, USA.
Onco Targets Ther ; 12: 8003-8014, 2019.
Article in En | MEDLINE | ID: mdl-31686856

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Onco Targets Ther Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Onco Targets Ther Year: 2019 Document type: Article Affiliation country: Country of publication: